SILENCE THERAP. SP.ADR/1 (XRP2) — Defensive Interval Ratio
SILENCE THERAP. SP.ADR/1 (XRP2) has a Defensive Interval Ratio of 1980 days as of December 2025. Defensive assets of €73.84 Million (cash €-, short-term investments €73.84 Million, receivables €0.00) cover 1980 days of daily cash needs of €37.30K/day. See working capital position of SILENCE THERAP. SP.ADR/1 to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
SILENCE THERAP. SP.ADR/1 Defensive Interval Ratio (2021–2025)
This chart shows how SILENCE THERAP. SP.ADR/1's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 1980 days, meaning defensive assets of €73.84 Million can fund 1980 days of operations without new revenue. See net asset quality index of SILENCE THERAP. SP.ADR/1 to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for SILENCE THERAP. SP.ADR/1 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for SILENCE THERAP. SP.ADR/1 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see SILENCE THERAP. SP.ADR/1 stock valuation.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1980 days | €73.84 Million | €37.30K/day | €- | €73.84 Million | ▲ +1394 days |
| 2024 | 585 days | €26.98 Million | €46.09K/day | €- | €26.00 Million | ▲ +581 days |
| 2023 | 5 days | €290.00K | €61.19K/day | €- | €0.00 | ▼ -282 days |
| 2022 | 287 days | €20.87 Million | €72.75K/day | €- | €19.76 Million | ▲ +279 days |
| 2021 | 8 days | €446.73K | €56.08K/day | €- | €0.00 | — |